Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients

Semin Thromb Hemost. 2023 Feb;49(1):85-88. doi: 10.1055/s-0042-1750024. Epub 2022 Jun 23.

Authors

John G Rizk¹, Jose G Lazo Jr², Aashish Gupta³, Carl J Lavie³, Mark B Effron³

Affiliations

¹ Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.
² Department of Pharmacy, UCSF Medical Center, University of California San Francisco, San Francisco, California.
³ Department of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana.

PMID: 35738295
DOI: 10.1055/s-0042-1750024

No abstract available

MeSH terms

Anticoagulants / therapeutic use
COVID-19 Drug Treatment
COVID-19*
Humans
Outpatients
Ritonavir* / therapeutic use

Substances

Ritonavir
nirmatrelvir
Anticoagulants